Consolidated Capital Management’s Labcorp LH Stock Holding History

Consolidated Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$212K	Buy	+795	New	+$215K	0.07%	69

Other funds holding LH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Consolidated Capital Management's LH Position: Q1 2026 in Review

Consolidated Capital Management opened a new position in Labcorp (LH) in Q1 2026: 795 shares worth $212K. The stake represents 0.07% of the portfolio and ranks #69 among its holdings.

1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

Consolidated Capital Management held 795 shares of Labcorp worth $212K as of Q1 2026.
Labcorp was a new Consolidated Capital Management position in Q1 2026.
Labcorp made up 0.07% of Consolidated Capital Management's portfolio in Q1 2026, its #69 holding.
1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Consolidated Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.